With Sentri7, we were able to showcase the value of our pharmacy team and make deep impacts shortly after implementation. We are given the tools needed to be successful and can drive initiatives and make changes quickly and with ease.
Solution benefits include:
- Improve antimicrobial agent selection
- Reduce redundant coverage and medication-bug mismatches
- Optimize medication dosing and track restricted medications
- Suggest therapeutic substitutes
- Appropriately speed IV-to-oral conversions or reduce the duration of antibiotic therapy
- Leverage AI-powered C. diff infection risk score to address modifiable risk factors
- Streamline vancomycin dosing with Bayesian dosing solutions
- ONC HIT-certified solution for required CMS AUR reporting
- Access system-level insights and SAAR data to improve performance
Sentri7® Pharmacy
Real-time identification of at-risk patients, consistent evidence-based, Medication Management guidance and robust analytics to drive improvements in medication use, cost containment, Bayesian dosing, antimicrobial stewardship, and opioid stewardship.
Sentri7 is an NHSN-validated antimicrobial use and antimicrobial resistance reported solution
As a validated provider, you can be confident your Antimicrobial Use and Antimicrobial Resistance data submitted by Sentri7 complies with the National Healthcare Safety Network (NHSN) protocols.
Since 2021, NHSN requires all production AU Summary Clinical Document Architecture (CDA) files contain an SDS Validation ID, which is provided by the NHSN to each vendor after successful validation. The same requirement has been in place for AR data beginning in May 2023.